Jasper Therapeutics Stock (NASDAQ:JSPR), Quotes and News Summary

Q: What sector and industry does Jasper Therapeutics (JSPR) operate in?

Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Jasper Therapeutics Stock (NASDAQ: JSPR) stock price, news, charts, stock research, profile.

Open	$21.180
Close	$20.400
Volume / Avg.	52.241K / 113.554K
Day Range	20.150 - 21.560
52 Wk Range	4.000 - 31.010
Market Cap	$348.627M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	3.03%
Days to Cover	4.65

Recent News

Over $15M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed mixed on Friday, there were a few notable insider trades.

Avi Kapoor

Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of FMC Corporation (NYSE: FMC) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter results.

Avi Kapoor

$4M Bet On Jasper Therapeutics? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed higher by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.6

Strong Buy

Buy

Hold

Sell

Strong Sell

About Jasper Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures throug...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Jasper Therapeutics (JSPR) stock?

You can purchase shares of Jasper Therapeutics (NASDAQ: JSPR) through any online brokerage.

View our list of the best stock brokerages.

Who are Jasper Therapeutics's (JSPR) competitors?

Other companies in Jasper Therapeutics’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), Opthea (NASDAQ:OPT), Monte Rosa Therapeutics (NASDAQ:GLUE) and RAPT Therapeutics (NASDAQ:RAPT).

What is the target price for Jasper Therapeutics (JSPR) stock?

The latest price target for Jasper Therapeutics (NASDAQ: JSPR) was reported by Evercore ISI Group on Wednesday, April 3, 2024. The analyst firm set a price target for 65.00 expecting JSPR to rise to within 12 months (a possible 181.26% upside). 12 analyst firms have reported ratings in the last year.

Current Stock Price for Jasper Therapeutics (JSPR)?

The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $23.11 last updated April 18, 2024 at 5:28 PM EDT.

Does Jasper Therapeutics (JSPR) pay a dividend?

There are no upcoming dividends for Jasper Therapeutics.

When is Jasper Therapeutics (NASDAQ:JSPR) reporting earnings?

Jasper Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.

Is Jasper Therapeutics (JSPR) going to split?

There is no upcoming split for Jasper Therapeutics.

What sector and industry does Jasper Therapeutics (JSPR) operate in?

Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-